Serial Entrepreneurs of the Biohealth Capital Region A strong group of entrepreneurs ready and willing to innovate, fund and lead new bioscience companies is essential to the creation and sustainability of top-tier biohealth clusters. It is often referenced that the BioHealth Capital Region (BHCR) lacks a deep enough pool of qualified executive talent that is [….]
Reprogramming the Human Computer: Silicon Valley Meets Cell and Gene Therapy How will Cell and Gene Therapy Usher in a New Industrial Revolution? Cell and gene therapy companies are on the verge of transforming how we treat unmet medical needs such as cancer, rare diseases, genetic disorders and diabetes, to name only a few. By [….]
The Next Generation of Female Founders and Entrepreneurs Is Ready to Disrupt The BioHealth Industry Silicon Valley Bank (SVB) recently conducted a survey called, “Women in Technology Leadership 2019”, which examined tech and healthcare company startup data and demographics. Respondents were from the U.S., UK, Canada and China. SVB’s survey found that only 56% of [….]
What Does It Take to Build A Globally Competitive Biohealth Cluster? The Key Elements That Are Making the BioHealth Capital Region A Premier Global Destination for BioHealth Companies The BioHealth Capital Region (BHCR) continues to thrive and currently occupies the fourth spot in the most recent Genetic Engineering & Biotechnology (GEN) top ten U.S. biohealth [….]
Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, including cell and gene therapy, have fundamentally changed the way life science companies see rare disease drug development. Life science giants like Pfizer, Merck and [….]
Viela Bio Becomes Latest Biotech Intent on Going Public with $150M Offering AstraZeneca spinout files for IPO on Nasdaq August 29, 2019 Viela Bio, the AstraZeneca spin-off biotech, has captured the attention of industry insiders since their $250M Series A investment that launched the company in 2018 and they are continuing to do becoming the [….]
These Female Executives Set the Standard of Excellence in the Biohealth Capital Region August 27, 2019 Liftstream, a U.K.-based executive recruiting firm, released an oft referenced report called “A Public Reality for Women in Biotech Boardrooms” in 2016. Lifstream’s research found that only 7 to 9 percent of biotech CEOs were women, less than 11 [….]
TEDCO’s Maryland Innovation Initiative Fund Continues to Deliver Substantial Impact for Maryland Biohealth Companies August 20, 2019 The Maryland Technology Development Corporation’s (TEDCO) Maryland Innovation Initiative (MII), a program designed to propel research from partner universities towards commercialization, has had a strong, demonstrable impact on many important life science portfolio companies in the BioHealth Capital [….]
Two Frederick, Maryland MedTech Companies Receive FDA 510K Approvals August 13, 2019 Frederick County, Maryland continues to be a vibrant hub for growing bioscience organizations. With its robust life science support ecosystem and proximity to key government research entities the region continues to produce and nurture exciting biotech companies across a wide range of fields, [….]
New TEDCO Task Force Created to Improve Venture Capital and Support Opportunities for Women Entrepreneurs The world-cup winning U.S. women’s soccer team and any number of 2020 presidential candidates have kept the gender pay gap front and center in recent 24-hour news cycles. In Biotech, where Female executives are a rarity, the gender gap issue [….]
